Bruker Corporation (BRKRP) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Bruker Corporation (BRKRP) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $8.37B, listed on NASDAQ, employing roughly 11,085 people, carrying a beta of 1.39 to the broader market. Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. Led by Frank H. Laukien, public since 2025-09-04.

Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BRKRP as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how max pain is reported and how to read the data →